| |
Our portfolio
Our
portfolio | Investment Guidelines |
Valuation Guidelines
|
Performance of ProgressNow!
|
as
per 31.01.2012
|
| Share price (SWX Swiss
Exchange) |
CHF 6.50 |
| Performance since 1.1.2011 |
-24.4% |
| Net Asset Value (preliminary unaudited
figure) |
CHF 12.16 |
|
Portfolio
|
as per 31.01.2012 |
| Company |
Amount |
Historical
price |
Current
valuation
per share |
+ / - |
Fair value
(in CHF) |
% of
portfolio |
| Enablearning, Inc | 1'452'905 | USD 0.87 | USD 0.00 | -100.0% | 0.00 | 0.0% | | Hansen Medical, Inc | 63'011 | USD 5.60 | USD 3.12 | -44.3% | 180'925.75 | 2.5% | | Oceanlinx Ltd | 348'179 | AUD 2.00 | AUD 0.35 | -82.5% | 118'925.76 | 1.7% | | Velico Medical, Inc | 9'906'585 | USD 0.92 | USD 0.75 | -18.4% | 6'837'772.63 | 95.8% |
|
Total (in CHF)
|
7'137'624.14 |
100.0% |
Exchange rate in CHF | | USD | 0.9203 | | AUD | 0.9759 | | GBP | 1.4505 |
|
|
